1187190-69-7

Basic information

• Product Name: 6-Chloro-4-methoxypyridine-3-carbonitrile
• Synonyms: 6-Chloro-4-methoxypyridine-3-carbonitrile;6-chloro-4-Methoxynicotinonitrile;6-Chloro-4-Methoxy-Nicotinonitrile Achiral 73.43;6-Chloro-4-Methoxy-Nicotinonitrile(WX683504)
• CAS NO: 1187190-69-7
• Molecular Formula: C7H5ClN2O
• Molecular Weight: 168.5804
• Mol File: 1187190-69-7.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 6-Chloro-4-methoxypyridine-3-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Chloro-4-methoxypyridine-3-carbonitrile(1187190-69-7)
• EPA Substance Registry System: 6-Chloro-4-methoxypyridine-3-carbonitrile(1187190-69-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 1187190-69-7(Hazardous Substances Data)

Usage

General Description

6-Chloro-4-methoxypyridine-3-carbonitrile is a chemical compound with the molecular formula C7H5ClN2O. It is a pyridine derivative with a chlorine atom and a methoxy group attached to the fourth and third carbon atoms, respectively, and a cyano group attached to the third carbon atom. 6-Chloro-4-methoxypyridine-3-carbonitrile is used as a building block in the synthesis of pharmaceutical and agrochemical products. It is known for its versatile reactivity and is commonly used as an intermediate in the production of various drugs and agricultural chemicals. Additionally, it is used in research and development to create new compounds with potential biological activities.

Upstream product

• 67-56-1 methanol 
• 166526-03-0 4,6-dichloropyridine-3-carbonitrile 
• 124-41-4 sodium methylate 
• 880870-13-3 5-bromo-2-chloro-4-methoxypyridine 
• 70593-57-6 4,6-dichloro-nicotinamide 
• 73027-79-9 4,6-dichloro-nicotinic acid 
• 17228-69-2 2-chloro-4-methoxy-pyridine 
• 557-21-1 zinc(II) cyanide 

Downstream Products

• 1438416-86-4 6-((4-bromophenyl)amino)-4-methoxynicotinonitrile 

Relevant articles and documents

HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS

The present invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; (I) which are inhibitors of WDR5. The present invention also provides pharmaceutical compositions comprising such compounds, compositions comprising such compounds with an additional therapeutic agent and the therapeutic uses of such compounds.

N-(2-(4-((1R,3R)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENOXY)ETHYL)PROPAN-1-AMINE DERIVATIVES AND RELATED COMPOUNDS AS SELECTIVE DOWN-REGULATORS OF THE ESTROGEN RECEPTOR FOR TREATING CANCER

The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, pharmaceutical compositions containing them and to the compounds of Formula (I) for use as selective down-regulators of the estrogen receptor in the treatment of cell proliferative disorders, such as cancer.

Inhibitors of the renal outer medullary potassium channel

This invention relates to compounds of Formula I having the following general structure: [in-line-formulae]Z1—Y1—(CH2)n1—R—(CH2)n2—Y2—Z2 [/in-line-formulae] wherein R